Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD — Willem Collier (2023) | RDL Network
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD
Article 2023 en
Authors
WC
Willem Collier
LI
Lesley A. Inker
BH
Benjamin Haaland
Abstract
1 min read
These analyses indicate consistency of the performance of total slope over 3 years, which provides further evidence for its validity as a surrogate end point in RCTs representing varied CKD populations.
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.